Ablation of recurrent primary liver cancer using 131I-lipiodol.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1648718.
- Also identified by PMC identifier 2398799.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A case of recurrent hepatocellular carcinoma following resection is reported. The patient received 2 treatments of 131I-lipiodol administered via the hepatic artery at angiography. Good localization in tumour tissue was observed on subsequent computed tomographic scans and no adverse effects were seen after either treatment. After the first treatment 2 nodules of recurrent tumour were resected and proved to be totally necrotic. The patient remains well 9 months later with a persistently elevated serum alphafetoprotein but no evidence of residual tumour. It is suggested that 131I-lipiodol may be the treatment of choice for small tumours in elderly high-risk patients.
Medical subject headings
- Carcinoma, Hepatocellular
- Iodine Radioisotopes
- Iodized Oil
- Liver Neoplasms
- Neoplasm Recurrence, Local